Yasmine Assadipour, M.D.
Taking care of patients and helping them through what can be a very stressful time in their life gives me a sense of purpose and makes me excited to come to work every day. I want my patients to feel safe, comfortable, have a good understanding of their surgical issue, know what to expect from surgery, and to be assured they have my full support throughout their recovery. I am most proud of the minimally invasive and advanced techniques in Endocrine Surgery I can offer to patients to help them have the most effective and most cosmetically optimal outcome. As an active researcher in the field of Endocrine Surgery, I stay up-to-date on the latest advancements in my field and am a contributing member of the American College of Surgeons and the American Association of Endocrine Surgeons.
In my spare time I enjoy painting, sculpture, playing the flute, doing yoga, and spending time with my family and friends. My career has been influenced by my mentor, Dr. Steven Rosenberg at the National Institutes of Health, who with all of his accomplishments remained humble and devoted to the care of our number one priority, the patient.
Learn more about Yasmine Assadipour, M.D.
Inova Fair Oaks Hospital
Inova Fairfax Hospital
Reston Hospital Center
Mount Sinai School of Medicine
George Washington University Hospital
University of California – Endocrine Surgery
National Institutes of Health – Surgical Oncology
American College of Surgeons
American Association of Endocrine Surgeons
American Thyroid Association
- End-organ effects of primary hyperparathyroidism: A population-based study.
- SDHB mutation status and tumor size but not tumor grade are important predictors of clinical outcome in pheochromocytoma and abdominal paraganglioma.
- The utility of 68 Gallium-DOTATATE PET/CT in the detection of von Hippel-Lindau disease associated tumors.
- Characterization of an Immunogenic Mutation in a Patient with Metastatic Triple-Negative Breast Cancer.
- Pediatric patients with pheochromocytoma and paraganglioma should have routine preoperative genetic testing for common susceptibility genes in addition to imaging to detect extra-adrenal and metastatic tumors.
- Prospective evaluation and treatment of familial carcinoid small intestine neuroendocrine tumors (SI-NETs).